DA
DCF Advisers Portfolio holdings
AUM
$264M
1-Year Est. Return
36.95%
1 Year Est. Return
+36.95%
AUM
$264M
AUM Growth
+$56.1M
(+27%)
Holding
99
Top Buys
| 1 | +$3.74M | |
| 2 | +$1.73M | |
| 3 | +$1.51M | |
| 4 |
Eli Lilly
LLY
|
+$1.28M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$1.09M |
Top Sells
| 1 | +$5.45M | |
| 2 | +$5.13M | |
| 3 | +$4.44M | |
| 4 |
AstraZeneca
AZN
|
+$3.2M |
| 5 |
Corvus Pharmaceuticals
CRVS
|
+$3.03M |
Sector Composition
| 1 | Healthcare | 29.21% |
| 2 | Technology | 25.23% |
| 3 | Communication Services | 8.11% |
| 4 | Financials | 4% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Micron Technology
MU
$271B
| $34.3M | 11.04% |
205,250
+9,000
|
|
||
2
Alphabet (Google) Class C
GOOG
$3.75T
| $13.9M | 4.46% |
57,000
|
|
||
3
argenx
ARGX
$54.1B
| $10.1M | 3.24% |
13,650
|
|
||
4
VanEck Gold Miners ETF
GDX
$25.2B
| $8.75M | 2.81% |
114,500
+12,000
|
|
||
5
Oracle
ORCL
$542B
| $8.16M | 2.62% |
29,000
-4,500
|
|
||
6
Teva Pharmaceuticals
TEVA
$34.2B
| $7.43M | 2.39% |
367,700
+185,200
|
|
||
7
iShares Gold Trust
IAU
$67.1B
| $7.28M | 2.34% |
100,000
|
|
||
|
8
Ionis Pharmaceuticals
IONS
$13.1B
| $7.09M | 2.28% |
108,413
+16,663
|
|
||
9
Amazon
AMZN
$2.42T
| $6.42M | 2.06% |
29,250
-6,600
|
|
||
|
10
Eli Lilly
LLY
$920B
| $6.33M | 2.03% |
8,300
+1,675
|
|
||
11
Bank of America
BAC
$403B
| $6.17M | 1.98% |
119,500
|
|
||
12
Regeneron Pharmaceuticals
REGN
$77.9B
| $5.62M | 1.81% |
10,000
+600
|
|
||
13
SPDR Gold Trust
GLD
$145B
| $5.33M | 1.71% |
15,000
|
|
||
14
Advanced Micro Devices
AMD
$343B
| $5.26M | 1.69% |
32,500
-2,500
|
|
||
15
Baidu
BIDU
$43B
| $5.2M | 1.67% |
39,500
-13,000
|
|
||
16
NewAmsterdam Pharma
NAMS
$4.22B
| $4.98M | 1.6% |
175,250
+2,750
|
|
||
17
Evotec
EVO
$1.07B
| $4.35M | 1.4% |
1,198,993
+84,500
|
|
||
18
iShares Silver Trust
SLV
$31.8B
| $4.24M | 1.36% |
100,000
|
|
||
19
Cisco
CSCO
$307B
| $4.11M | 1.32% |
60,000
+2,500
|
|
||
20
Citigroup
C
$200B
| $3.65M | 1.17% |
36,000
|
|
||
21
Incyte
INCY
$18.7B
| $3.52M | 1.13% |
41,500
|
|
||
22
Lifecore Biomedical
LFCR
$292M
| $3.33M | 1.07% |
452,000
-10,987
|
|
||
23
Amgen
AMGN
$171B
| $3.25M | 1.04% |
11,500
+1,000
|
|
||
24
Zai Lab
ZLAB
$1.97B
| $3.12M | 1% |
92,000
+1,000
|
|
||
25
Zimmer Biomet
ZBH
$18.2B
| $3M | 0.97% |
30,500
-150
|
|